medline.ch Onkologie Gynäkologische Tumoren

	Al18F-NOTA-FAPI-04 PET/CT for diagnosis of breast cancer and its correlation with pathological features: A single-center retrospective study. PLoS One Wang Y, Feng L, He L, Liu N, Wang H. PMID: 41678503 [PubMed - indexed for MEDLINE]
	Sleep, Depressive Symptoms, and Quality of Life Among Women With Newly Diagnosed Breast Cancer: Baseline Results From the AMBER Cohort Study. Cancer Med Yang L, Tayyab T, Kokts-Porietis RL, Wang Q, McNeil J, Matthews CE, Dickau L, Vallance JK, McNeely ML, Culos-Reed SN, Kopciuk KA, Courneya KS, Friedenreich CM. PMID: 41678369 [PubMed - indexed for MEDLINE]
	Addressing the Challenges in the Identification of HER2-Low and Ultralow Breast Cancer in Asia: A Delphi Consensus. Adv Ther Shah M, Yolo RT, Hernowo BS, Cong TN, Gyungyub G, Irianiwati, Kim LB, Madrid MA, Rajadurai P, Sampatanukul P, Ueng SH, Pasricha S, Tan BY, Tan PH, Jitpasutham T. PMID: 41678134 [PubMed - as supplied by publisher]
	Muscle quality during cancer treatment and associations with health-related quality of life. Qual Life Res Rodrigues JL, O'Connell NS, Sutton AL, Ruddy KJ, Weaver KE, Lesser GJ, Ky B, D'Agostino RB Jr, Hundley WG, Bellissimo MP. PMID: 41678067 [PubMed - indexed for MEDLINE]
	Understanding, Recognizing, and Managing Cancer-Related Fatigue Associated with Breast Cancer. Curr Treat Options Oncol Peng L, Wang X, Zhang C, Liu T, Luo X, Li Z. PMID: 41678031 [PubMed - in process]
	Axillary Extranodal Extension in Breast Cancer: Imaging Features With Histopathology Correlation. J Breast Imaging Nguyen PT, Portnow LH, Packer MD, Gombos EC. PMID: 41677770 [PubMed - as supplied by publisher]
	Extracellular Vesicle Associated Proteomic Biomarkers in Breast Cancer: A Systematic Review and Meta-Analysis. Cells Al-Mahrouqi N, Al-Sayegh H, Al-Zadjali S, Khan AA. PMID: 41677598 [PubMed - indexed for MEDLINE]
	Prevalence of BRCA1 and BRCA2 Germline Mutations in Vietnamese Patients With Triple-Negative Breast Cancer. Cancer Control Toan TT, To TV, Lan TTH, Thinh NV, Anh DTN, Hanh BTM. PMID: 41676859 [PubMed - indexed for MEDLINE]
	Clinical outcome and tolerability of DS-8201 in patients with advanced HER2-positive breast cancer: a retrospective study. Am J Transl Res Wu W, Zhang R, Zhao Y, Lu X. PMID: 41676255 [PubMed]
	Development and validation of an interpretable machine learning model identify the lactylation-related protein SUSD3 as a prognostic and therapeutic biomarker for breast cancer. Front Immunol Tang L. PMID: 41676158 [PubMed - indexed for MEDLINE]
	Integrative bioinformatics approaches for early detection biomarkers in ovarian cancer. Ann Med Surg (Lond) Obeagu EI. PMID: 41675779 [PubMed]
	Thrombopoiesis meets tumorigenesis: unlocking the diagnostic and prognostic potential of platelet indices in breast cancer- a narrative review. Ann Med Surg (Lond) Obeagu EI. PMID: 41675754 [PubMed]
	Radiologic imaging and its current importance in breast cancer management. Front Radiol Dagar N, Sarin M, Yadav P, Thidwar R. PMID: 41675437 [PubMed]
	Immuno-oncological effects of aerobic exercise combined with anti-PD-L1 antibody blockade in a murine breast cancer model. Front Oncol Hekmatikar AA, Agha-Alinejad H, Yousefi-Ahmadipour A, Shamsi MM, Daud DMA. PMID: 41675286 [PubMed]
	BRCA and CDK4/6: allies or antagonists?-efficacy of CDK4/6 inhibitors in HR(+)/HER2(-) breast cancer with germline BRCA1/2 mutations: a narrative review. Transl Breast Cancer Res Illia MF, Colucci G, Rodriguez Mignola A, Eiben M, Ballester AM, Zeff N, Paesani F, Crimi G, Von Stecher F, de la Vega M, Perazzo F, Mandó P. PMID: 41675010 [PubMed]
	Chinese expert consensus on endocrine therapy for breast cancer (2026 edition). Transl Breast Cancer Res Yuan Y, Yin Y, Wang S, Liu Y, Yang J, Yan M, Mo X, Pan Y, Wang X, Wang H, Li J, Wang S, Wu J, Song E, Jiang Z, Chinese Consensus Group on Breast Cancer Endocrine Therapy. PMID: 41675009 [PubMed]
	The preliminary study on the effect of PSEN1 on the proliferation and invasion of breast cancer cells. Transl Breast Cancer Res Yang M, Zou JQ, Yang W. PMID: 41675007 [PubMed]
	Biomarkers of primary and secondary resistance to cyclin dependent kinases 4 and 6 inhibitors in metastatic estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast cancer: a narrative review. Transl Breast Cancer Res Stravodimou A, Voutsadakis IA. PMID: 41675006 [PubMed]
	Real-world efficacy and prognostic factors of CDK4/6 inhibitors in HR(+)/HER2(-) metastatic breast cancer: a multicenter retrospective study from the Dongting Lake region of China. Transl Breast Cancer Res Liu B, Wu T, Lu K, Chen J, Zhou Q, Liu L, Tian C, Hu ZY, Tang Y, Ouyang Q, Xie N. PMID: 41675004 [PubMed]
	Social inequalities in survival among women with breast cancer in southeastern Brazil: a retrospective cohort study. Transl Breast Cancer Res Pessanha RM, Grippa WR, Neto LCBS, Dell'Antonio LS, Dell'Antonio CSDS, Lopes-Júnior LC. PMID: 41675003 [PubMed]

Artikel 1 - 20 / 324311

Seite 1 von 16216

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung